National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 3) (PB 29 of 2017) (Cth)

PB 29 of 2017

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 3)

National Health Act 1953

I, LOUISE CLARKE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 27 April 2017

LOUISE CLARKE

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 3)

(2)This Instrument may also be cited as PB 29 of 2017.

2          Commencement

This Instrument commences on 1 May 2017.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1

omit:

Aciclovir Tablet 800 mg 20 120 5

1. Schedule 1, after entry for Daclatasvir in the form Tablet 60 mg [Maximum Quantity: 28; Number of Repeats: 5]

insert:

Daclizumab Injection 150 mg in 1 mL pre-filled pen 20 1 5

1. Schedule 1

omit:

Gestrinone Capsule 2.5 mg 20 8 5

1. Schedule 1, after entry for Nilutamide

insert:

Nintedanib	Capsule 100 mg	20	60	5
Nintedanib	Capsule 150 mg	20	60	5

1. Schedule 1, after entry for Temozolomide in the form Capsule 5 mg [Maximum Quantity: 15; Number of Repeats: 2]

insert:

Tenofovir alafenamide with emtricitabine, elvitegravir and cobicistat Tablet containing tenofovir alafenamide 10 mg with emtricitabine 200 mg, elvitegravir 150 mg and cobicistat 150 mg 20 60 5

1. Schedule 1

omit:

Verapamil	Capsule containing verapamil hydrochloride 160 mg (sustained release)	20	30	5
Verapamil	Capsule containing verapamil hydrochloride 240 mg (sustained release)	20	30	5